Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 3 (KRT8P3) is a human gene classified as a pseudogene. Unlike functional keratin genes (such as KRT8), it does not encode a protein or participate in cellular structural or regulatory processes. Pseudogenes like KRT8P3 may arise from duplication or retrotransposition events and generally do not produce functional products due to disruptions in their coding sequences. KRT8P3 is not considered a drug target, diagnostic biomarker, or therapeutic molecule, and current literature provides no evidence for clinical or biological roles; it is often listed only in genomic annotation resources. It has no known biological, therapeutic, or clinical function. Current scientific databases and publications only annotate it for reference/genomic purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 3 (KRT8P3).